Quick answer
Most complications of EchoLaser are mild and short-lived. In the European guideline, they are mostly grades I and II on the Clavien-Dindo scale, and major ones occur in fewer than 5% of men.1 The ones most often reported are trouble urinating when the catheter comes out, urinary infection and pain in the perineum.1 A prostate abscess is rare, 0.6% to 4.8%, and is treated with drainage and antibiotics.3 I explain each risk before treatment.
How serious they are
In a review of 17 studies, EchoLaser complications were mainly grade I and II, and none went beyond grade III.4 In an Italian series of 100 men treated under local anesthesia with no hospital stay, 2% had a urinary infection treated with oral antibiotics (grade II), and none had a complication of grade III or higher.5 In a series of 85 men with prostates over 80 g, complications added up to 22.4%, almost all grade II or lower.9
The complications, one by one
The figures vary a lot from one study to another, because the studies are small and the technique varies between centers.15 In the first days and weeks:
| Early complication | Frequency | Study |
|---|---|---|
| Burning when urinating | 3.7% to 36.3% | Review of 11 studies3 |
| Trouble urinating when the catheter comes out | 1.9% to 19% | Review of 11 studies3 |
| Short-lived perineal pain | 19.4% | 36 men in Turkey12 |
| Urinary infection or inflammation of the testicle | 0.6% to 9.1% | Review of 11 studies3 |
| Prostatitis | 2.5% | Review of minimally invasive techniques11 |
| Blood in the urine | 1.9% to 2.3% | Review of 11 studies3 |
| Prostate abscess | 0.6% to 4.8% | Review of 11 studies3 |
| Transfusion | No cases | Review of 11 studies3 |
In the following months:
| Late complication | Frequency | Study |
|---|---|---|
| Loss of ejaculation | 5% | Analysis of the studies of minimally invasive techniques14 |
| Change in erections | Generally preserved or improved | European guideline1 |
| Treatment that did not work within about 12 months | 9% | 100 men in Italy5 |
| Urethral narrowing | No cases described | Review of minimally invasive techniques11 |
Trouble urinating when the catheter comes out
In the review of 11 studies, trouble urinating after catheter removal ranged from 1.9% to 19%. In the Italian randomized trial that compared EchoLaser with TURP, it occurred in 19% (5 of 26 men), and most cases were in men whose catheter came out at 3 to 4 days.3 In a series of 22 men, it was 13.6%.8 In a series of 85 men with prostates over 80 g, the catheter could not be removed on day 7 in 24.7% and on day 14 in 7.1%, and 3.5% still needed it after 30 days.9 In practice, prostate size has to be assessed case by case.
When urine does not come, a new catheter is placed, which counts as grade II.3 In my practice, the catheter stays for 7 days and I remove it at my office.
Urinary infection, prostatitis and inflammation of the testicle
In the review of 11 studies, urinary infection or inflammation of the testicle (orchitis) appeared in 0.6% to 9.1% of men. Most were grade II complications, treated with antibiotics.3 In the series of 100 men, it was 2%, treated with oral antibiotics.5 In a series of 63 men, one had orchitis (1.6%), which improved with antibiotics.6 A more recent review cites prostatitis in 2.5%.11 In an American series of 35 men, almost half of whom had already had a urinary infection or a bloodstream infection (urosepsis) before treatment, one man had urosepsis and needed to be admitted.13
In the studies, an antibiotic is usually given within an hour before the procedure and, at some centers, continued for up to 7 days. Men with an active urinary infection, prostatitis or a past prostate abscess are usually left out of the studies.3 Prostatitis has its own page.
Prostate abscess
An abscess is a collection of pus inside the prostate. In the review of 11 studies, it appeared in 0.6% to 4.8% of men and was the only grade III complication described. Treatment was drainage and a longer course of antibiotics.3
In an Italian series of 21 men, an abscess was the only complication, treated with drainage through the perineum and antibiotics.7 In the series of 63 men, two had an abscess (3.2%), both drained successfully.6 In the series of 85 men with prostates over 80 g, there was 1 case (1.2%).9
Blood in the urine and bruising
Blood in the urine appeared in 1.9% to 2.3% of the men in the review of 11 studies, and none needed a transfusion.3 Another review cites blood in the urine in 1.9% to 15% and a bruise (hematoma) in the perineum in 8.3%.11 In the series of prostates over 80 g, there were no transfusions either.9
Taking a blood thinner was not a reason to leave men out of the studies.3 In my practice, the decision about the blood thinner for EchoLaser is made case by case, together with the doctor who prescribed it.
Burning and perineal pain
Burning when urinating ranged from 3.7% to 36.3% in the review and was generally grade I.3 In a series of 36 men in Turkey, 16.7% had burning and 19.4% had short-lived perineal pain, and all improved without needing surgery.12 In the series of 100 men, one stayed in hospital overnight for pelvic pain.5
The urethra and bladder control
The needles stay at a safe distance from the urethra (about 8 mm) and from the bladder neck (about 15 mm), and ultrasound follows the treatment the whole time.3,5 One review found no described cases of urethral narrowing. In one study of 20 men, there was one case of a burn to the urethra.11 In the series of prostates over 80 g, there was no urethral narrowing, and mild, short-lived urine leakage appeared in 1.2%.9
Ejaculation and erections
In the review of 11 studies, more than 95% of men kept their ejaculation.3 In the Italian randomized trial, one month later, 96% still ejaculated after EchoLaser, compared with 28% after TURP.3 In the European guideline, more than 85% of sexually active men keep their ejaculation.1 In an analysis that pooled the studies of minimally invasive techniques, loss of ejaculation with EchoLaser was 5%.14 Another review cites loss in 1.2% to 15%.11
In the European guideline, erections are generally preserved or improved.1 In a series of 36 sexually active men, the erectile function score dropped in the first two weeks and returned to its previous level by 1 month.12 What changes with each technique is in ejaculation and erections after each technique.
Repeat treatment
In the series of 100 men, followed for about 12 months, the treatment did not work in 9%: 7 needed TURP or HoLEP, and 2 stayed on a catheter. Of the 14 men who already had a catheter before EchoLaser, 9 went back to urinating without it. According to the authors, in the men who needed another operation, the earlier EchoLaser did not harm the result.5
In a series of prostates of 80 g or more, 9% needed another operation within about 12 months,10 and in the series of prostates over 80 g, 12.9% later had HoLEP, over a follow-up of about 18 months.9 In practice, this has to be assessed case by case.
Most studies followed the men for up to 12 months, which limits what is known about repeat treatment and late complications.15 The European guideline calls for larger and longer randomized trials.1
What lowers the risk
Catheter time. In the Italian randomized trial, most cases of retention were in men whose catheter came out at 3 to 4 days, and most men in the studies had the catheter removed successfully after at least 7 days.3 In my practice, the catheter stays for 7 days.
Antibiotics and patient selection. The studies give an antibiotic before the procedure and leave out men with an active infection, prostatitis or a past abscess.3
Safety distances. The distance from the urethra and the bladder neck, checked on ultrasound before the laser is switched on, protects the urethra and ejaculation.3,5
Prostate size. In the series of prostates over 80 g, the catheter could not be removed on day 7 in almost 1 in 4 men.9 In practice, this has to be assessed case by case. I compare EchoLaser with the other techniques, as I explain in which technique for each prostate size.
How I approach it
I have performed EchoLaser since 2025, when the technique arrived in Brazil, and I did one of the first cases in the country. In my practice, it is done under local anesthesia and sedation, with a short hospital admission: you arrive and go home the same day. The catheter stays for 7 days and I remove it at my office. Work without physical effort and driving resume once the catheter is out, and the gym, heavy effort and sex after 30 days. The decision about the blood thinner is case by case.
Before recommending treatment, I explain each risk with the figures from the literature and what it means in your case. If you live outside São Paulo, you can go back to your city the same day, with the catheter, and have it removed there, or stay in São Paulo until it comes out. The first consultation and follow-up visits can be online, in English. How the treatment is done is in EchoLaser.
When to see a urologist
- If the catheter stops draining or if, after it comes out, you cannot urinate
- If you have a fever or chills
- If the perineal pain gets worse instead of better
- If the urine turns red or has clots that do not clear with drinking water
- If a testicle swells or hurts
- If the stream becomes weak again months after treatment
Frequently asked questions
Does EchoLaser have many complications?+
In the European guideline, EchoLaser complications are mostly mild (grades I and II on the Clavien-Dindo scale), and major ones occur in fewer than 5% of men.1 In a series of 100 men, 2% had a urinary infection treated with oral antibiotics, and none had a complication of grade III or higher.5
Is it common to be unable to urinate when the catheter comes out?+
In a review of 11 studies, trouble urinating after catheter removal ranged from 1.9% to 19%. In the study with the highest rate, most cases were in men whose catheter came out at 3 to 4 days. When it happens, a new catheter is placed.3
Can EchoLaser cause a prostate abscess?+
It can, but it is rare. In the review, an abscess appeared in 0.6% to 4.8% of men and was treated with drainage and antibiotics.3
Does EchoLaser bleed?+
In the review, blood in the urine appeared in 1.9% to 2.3% of men, and none needed a transfusion.3 In my practice, the decision about the blood thinner for EchoLaser is made case by case, together with the doctor who prescribed it.
Does EchoLaser change ejaculation and erections?+
In the review of 11 studies, more than 95% of men kept their ejaculation.3 In an analysis that pooled the studies of minimally invasive techniques, loss of ejaculation with EchoLaser was 5%.14 In the European guideline, erections are generally preserved or improved.1
What is the chance of needing another treatment after EchoLaser?+
In a series of 100 men followed for about 12 months, the treatment did not work in 9%: 7 needed TURP or HoLEP, and 2 stayed on a catheter.5 Follow-up in the studies is still short.15
When should I seek care after EchoLaser?+
If the catheter stops draining or, after it comes out, you cannot urinate, if you have a fever or chills, if the perineal pain gets worse instead of better, if the urine turns red or has clots that do not clear with drinking water, or if a testicle swells or hurts.
Who performs EchoLaser in São Paulo?+
I am Dr. Petronio Melo, a urologist and robotic surgeon in São Paulo, CRM-SP 157.598 and RQE 70.275. I have performed EchoLaser since 2025, when the technique arrived in Brazil, and I did one of the first cases in the country. I explain each risk before treatment. In my practice, it is done under local anesthesia and sedation, with a short hospital admission: you arrive and go home the same day. The catheter stays for 7 days and I remove it at my office. My office is in Vila Mariana, and the first consultation can be in person or online, in English.
References
- EAU Guidelines on the Management of Non-neurogenic Male LUTS. European Association of Urology; 2026. Disease management chapter. EAU
- Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-213. PubMed
- Tzelves L, Nagasubramanian S, Pinitas A, et al. Transperineal laser ablation as a new minimally invasive surgical therapy for benign prostatic hyperplasia: a systematic review of existing literature. Ther Adv Urol. 2023;15:17562872231198634. PubMed
- Alberti A, Lo Re M, Nicoletti R, et al. Transperineal laser ablation in the management of benign prostatic hyperplasia: an updated systematic review and pooled analysis. Prostate Cancer Prostatic Dis. 2026;29(2):222-238. PubMed
- Lo Re M, Polverino P, Rivetti A, et al. Transperineal laser ablation (TPLA) of the prostate for benign prostatic obstruction: the first 100 patients cohort of a prospective, single-center study. World J Urol. 2024;42(1):402. PubMed
- Laganà A, Di Lascio G, Di Blasi A, et al. Ultrasound-guided SoracteLite transperineal laser ablation (TPLA) of the prostate for the treatment of symptomatic benign prostatic hyperplasia (BPH): a prospective single-center experience. World J Urol. 2023;41(4):1157-1162. PubMed
- de Rienzo G, Lorusso A, Minafra P, et al. Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction. Eur Urol. 2021;80(1):95-103. PubMed
- Frego N, Saita A, Casale P, et al. Feasibility, safety, and efficacy of ultrasound-guided transperineal laser ablation for the treatment of benign prostatic hyperplasia: a single institutional experience. World J Urol. 2021;39(10):3867-3873. PubMed
- Conte FL, Saladino M, Lambertini L, et al. Safety and functional efficacy of transperineal laser ablation in large prostates (>80 mL): a prospective single-center study. Minerva Urol Nephrol. 2026;78(4):583-591. PubMed
- Polverino P, Moscardi L, Lo Re M, et al. Office-based transperineal laser ablation in patients with large prostates (≥80 mL): real-world evidence of safety and efficacy from a prospective single center cohort. Minerva Urol Nephrol. 2026. Published online ahead of print. PubMed
- Grossmann NC, Berjaoui MB, Choudhary O, et al. State-of-the-art in minimally invasive treatments for benign prostatic obstruction. Investig Clin Urol. 2026;67(1):1-14. PubMed
- Ozlulerden Y, Duzgun D, Celen S, et al. Patient and Partner Sexual Outcomes After Transperineal Laser Ablation for Benign Prostatic Hyperplasia: A 12-Month Longitudinal Study. J Clin Med. 2026;15(21):8599. PubMed
- Varela J, Bourricaudy RA, Cekin E, et al. Office-based transperineal laser ablation for benign prostatic hyperplasia: Functional outcomes and predictors of clinical improvement. Cent European J Urol. 2026;79(3):326-334. PubMed
- Franco A, Ditonno F, Manfredi C, et al. Systematic Review and Pooled Analysis of Functional and Sexual Outcomes of Minimally Invasive Surgical Treatments for Benign Prostatic Obstruction. Eur Urol. 2026;89(4):318-331. PubMed
- Pires IZ, Gobbo MODS, Fujimura AY, et al. Transperineal Laser Ablation for Treatment of Lower Urinary Tract Symptoms in Benign Prostate Enlargement: A Systematic Review and Meta-analysis. Int Braz J Urol. 2026;52(2):e20250423. PubMed
Would you like to talk about your case?
In the consultation, I go over your tests and your priorities.
Book a consultation
